[go: up one dir, main page]

DK1301207T3 - Sammensætninger til behandling af bakterieinfektioner indeholdende en oxazolidinonforbindelse, sulbactam og ampicillin - Google Patents

Sammensætninger til behandling af bakterieinfektioner indeholdende en oxazolidinonforbindelse, sulbactam og ampicillin

Info

Publication number
DK1301207T3
DK1301207T3 DK01952176T DK01952176T DK1301207T3 DK 1301207 T3 DK1301207 T3 DK 1301207T3 DK 01952176 T DK01952176 T DK 01952176T DK 01952176 T DK01952176 T DK 01952176T DK 1301207 T3 DK1301207 T3 DK 1301207T3
Authority
DK
Denmark
Prior art keywords
sulbactam
ampicillin
compositions
treatment
bacterial infections
Prior art date
Application number
DK01952176T
Other languages
Danish (da)
English (en)
Inventor
Donald H Batts
Keiichi Hiramatsu
Original Assignee
Pharmacia & Upjohn Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Co Llc filed Critical Pharmacia & Upjohn Co Llc
Application granted granted Critical
Publication of DK1301207T3 publication Critical patent/DK1301207T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
DK01952176T 2000-06-30 2001-06-21 Sammensætninger til behandling af bakterieinfektioner indeholdende en oxazolidinonforbindelse, sulbactam og ampicillin DK1301207T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US21541800P 2000-06-30 2000-06-30
US23277300P 2000-09-15 2000-09-15
US27930601P 2001-03-28 2001-03-28
PCT/US2001/019712 WO2002002095A2 (fr) 2000-06-30 2001-06-21 Composition et techniques de traitement d'infections bacteriennes

Publications (1)

Publication Number Publication Date
DK1301207T3 true DK1301207T3 (da) 2005-10-10

Family

ID=27396119

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01952176T DK1301207T3 (da) 2000-06-30 2001-06-21 Sammensætninger til behandling af bakterieinfektioner indeholdende en oxazolidinonforbindelse, sulbactam og ampicillin

Country Status (14)

Country Link
US (1) US6544991B2 (fr)
EP (1) EP1301207B1 (fr)
JP (1) JP2004501965A (fr)
AR (1) AR029544A1 (fr)
AT (1) ATE301474T1 (fr)
AU (1) AU2001272961A1 (fr)
DE (1) DE60112581T2 (fr)
DK (1) DK1301207T3 (fr)
ES (1) ES2245698T3 (fr)
MY (1) MY128739A (fr)
PE (1) PE20020295A1 (fr)
PT (1) PT1301207E (fr)
TW (1) TWI265030B (fr)
WO (1) WO2002002095A2 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9928568D0 (en) 1999-12-03 2000-02-02 Zeneca Ltd Chemical compounds
GB0009803D0 (en) 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
WO2003030906A1 (fr) * 2001-10-11 2003-04-17 Pharmacia & Upjohn Company Traitement d'infections par administration cutanee d'oxazolidinones
CN1642543A (zh) * 2002-03-29 2005-07-20 法玛西雅厄普约翰有限责任公司 治疗糖尿病性足部感染的噁唑烷酮肠胃外、静脉内和口服给药
WO2003093247A2 (fr) * 2002-04-30 2003-11-13 Orchid Chemicals & Pharmaceuticals Ltd Nouveaux agents antibacteriens
JP2008540431A (ja) * 2005-05-06 2008-11-20 ワイス ヘパリンの存在下でのチゲサイクリンの送達
JP2008544979A (ja) 2005-06-29 2008-12-11 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー 抗菌剤としてのホモモルホリンオキサゾリジノン
WO2007086013A1 (fr) * 2006-01-25 2007-08-02 Jegannathan Srinivas Préparation à base de ceftazidime, de tazobactam et de linézolide
WO2007086014A1 (fr) * 2006-01-25 2007-08-02 Jegannathan Srinivas Préparation à base de céfpirome, de tazobactam et de linézolide
WO2007086011A1 (fr) * 2006-01-25 2007-08-02 Jegannathan Srinivas Composition à base de céfépime, de tazobactam et de linézolide
WO2007086012A1 (fr) * 2006-01-25 2007-08-02 Jegannathan Srinivas Préparation de cefpodoxime, d'acide clavulanique et de linezolide
WO2008090570A1 (fr) * 2007-01-25 2008-07-31 Panacea Biotec Ltd Nouveaux antimicrobiens
KR20110092309A (ko) 2008-11-20 2011-08-17 파나세아 바이오테크 리미티드 신규 항균제
MX2012000231A (es) 2009-06-26 2012-03-07 Panacea Biotec Ltd Nuevos aza-biciclo-hexanos.
WO2017066964A1 (fr) 2015-10-22 2017-04-27 Merck Sharp & Dohme Corp. Composés oxazolidinone et procédés d'utilisation de ces derniers en tant qu'agents antibactériens
WO2021184339A1 (fr) 2020-03-20 2021-09-23 Merck Sharp & Dohme Corp. Composé d'oxazolidinone et procédés d'utilisation de celui-ci comme agent antibactérien

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2985648A (en) 1958-10-06 1961-05-23 Doyle Frank Peter Alpha-aminobenzylpenicillins
GB902703A (en) 1960-08-25 1962-08-09 Beecham Res Lab Penicillins
BE641785A (fr) 1962-12-26
US4234579A (en) 1977-06-07 1980-11-18 Pfizer Inc. Penicillanic acid 1,1-dioxides as β-lactamase inhibitors
SK283420B6 (sk) 1992-05-08 2003-07-01 Pharmacia & Upjohn Company Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny
US5688792A (en) 1994-08-16 1997-11-18 Pharmacia & Upjohn Company Substituted oxazine and thiazine oxazolidinone antimicrobials
DE4425613A1 (de) 1994-07-20 1996-01-25 Bayer Ag 5-gliedrige Heteroaryl-oxazolidinone
DE4425612A1 (de) 1994-07-20 1996-04-04 Bayer Ag 6-gliedrige stickstoffhaltige Heteroaryl-oxazolidinone
DE19514313A1 (de) 1994-08-03 1996-02-08 Bayer Ag Benzoxazolyl- und Benzothiazolyloxazolidinone
ES2165516T3 (es) 1995-09-01 2002-03-16 Upjohn Co Feniloxazolidinonas con un enlace c-c con anillos heterociclicos de 4-8 miembros.
DE19601264A1 (de) 1996-01-16 1997-07-17 Bayer Ag Pyrido-annellierte Thienyl- und Furanyl-Oxazolidinone
DE19601265A1 (de) 1996-01-16 1997-07-17 Bayer Ag 2-Oxo- und 2-Thio-1,2-dihydrochinolinyl-oxazolidinone
DE19601627A1 (de) 1996-01-18 1997-07-24 Bayer Ag Heteroatomhaltige Cyclopentanopyridyl-Oxazolidinone
US5684024A (en) 1996-01-25 1997-11-04 Viropharma Incorporated Pyrazole dimers compositions and methods for treating influenza
DE19604223A1 (de) 1996-02-06 1997-08-07 Bayer Ag Neue substituierte Oxazolidinone
GB9702213D0 (en) 1996-02-24 1997-03-26 Zeneca Ltd Chemical compounds
ES2166073T3 (es) 1996-04-11 2002-04-01 Upjohn Co Procedimiento para preparar oxazolidinonas.
SK286569B6 (sk) 1997-11-07 2009-01-07 Pharmacia & Upjohn Company Spôsob výroby oxazolidinónov
KR20010101890A (ko) 1999-02-01 2001-11-15 로렌스 티. 마이젠헬더 황-함유 시클릭 플루오르화 옥사졸리디논의 제조 방법

Also Published As

Publication number Publication date
EP1301207B1 (fr) 2005-08-10
ES2245698T3 (es) 2006-01-16
PT1301207E (pt) 2005-11-30
US20020022610A1 (en) 2002-02-21
TWI265030B (en) 2006-11-01
DE60112581D1 (de) 2005-09-15
DE60112581T2 (de) 2006-06-01
US6544991B2 (en) 2003-04-08
ATE301474T1 (de) 2005-08-15
MY128739A (en) 2007-02-28
PE20020295A1 (es) 2002-04-07
AR029544A1 (es) 2003-07-02
JP2004501965A (ja) 2004-01-22
AU2001272961A1 (en) 2002-01-14
WO2002002095A3 (fr) 2003-02-06
WO2002002095A2 (fr) 2002-01-10
WO2002002095B1 (fr) 2004-03-25
EP1301207A2 (fr) 2003-04-16

Similar Documents

Publication Publication Date Title
DK1301207T3 (da) Sammensætninger til behandling af bakterieinfektioner indeholdende en oxazolidinonforbindelse, sulbactam og ampicillin
GB0125222D0 (en) Composition for the treatment of microbial infections
NO20041428L (no) Oksazolidinon og/eller isoksazolin som antibakterielle midler.
SE0102315D0 (sv) Compounds
DK1448234T3 (da) Formuleringer, der omfatter en cephalosporinforbindelse, og deres anvendelse til behandling af bakterieinfektioner hos katte og hunde
ATE397928T1 (de) Glukokinase beeinflussende verbindungen
HK1049656A1 (zh) Fab i抑制剂
DK2128246T3 (da) Fremgangsmåder og sammensætninger til fremstilling af ortogonale tRNA-aminoacyl-tRNA-syntetasepar.
DK1562968T3 (da) Anti-il-6-antistoffer, sammensætninger, fremgangsmåder og anvendelser
IL158168A0 (en) 5-membered, nitrogen-containing heterocyclic compounds and pharmaceutical compositions containing the same
NO20025204D0 (no) Forbindelser og fremgangsmÕter for behandling og forebygging av bakterielle infeksjoner
DK1183269T3 (da) Svækkede mikroorganismer til behandlingen af infektion
ZA200101821B (en) Use of heteroaryl substituted n-(indole-2-carbonyl-) amides for treatment of infection.
NO20014314L (no) Blandinger og metoder for behandling av stafylokokkisk infeksjon
DK1380121T3 (da) Fremgangsmåde til fremstilling af oxazolidinoner
IL168747A0 (en) Oxazolidinone and/or isoxazoline derivatives as antibacterial agents
DK1656143T3 (da) Quinolon-antibiotika til behandling af periodontale infektioner
ATE405574T1 (de) Aryl-annellierte azapolyzyklische verbindungen
ITTO20020744A1 (it) Composizione.
DK1459748T3 (da) (S,S)-reboxetin til behandling af perifer neuropati
SI1301207T1 (sl) Sestavki za zdravljenje bakterijskih infekcij, ki vsebujejo oksazolidinonsko spojino, sulbaktam in ampicilin
ITTO20020745A1 (it) Composizione.
IL160490A0 (en) Systematical administration of some oxazolidinones, e.g. linezolid, for the treatment for ocular infections
DK1105101T3 (da) Fremgangsmåder og præparater til behandling af intracellulære infektioner
DK1411908T3 (da) Nitrogenoxidgenererende sammensætning til behandling af subunguale infektioner